3-(3-methyl-2-oxo-5-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione

Catalog No. :
ACNJVV871
CAS No. :
-
Molecular Formula :
C19H18F3N7O3
Molecular Weight :
449.39

IUPAC Name:3-(3-methyl-2-oxo-5-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione

3-(3-methyl-2-oxo-5-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00Login to see priceInquiryInquiry
250mg95%$715.00Login to see priceInquiryInquiry
1g95%$1590.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-methyl-2-oxo-5-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione
IUPAC Name3-(3-methyl-2-oxo-5-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione
Molecular FormulaC19H18F3N7O3
Molecular Weight449.39
SMILESCN1C(=O)N(C2CCC(=O)NC2=O)C2=CC=C(N3CCN4C(=NN=C4C(F)(F)F)C3)C=C21
InChI KeyFYWWJLIDSSMIOZ-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACNJVV871 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNJVV871 route product structure diagram
    ACNJVV871-
Inquiry

2. ACNJVV871 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIJSZ789 route compound structure diagram
    ACIJSZ7892300099-98-1 In Stock
  2. Plus
  3. ACATRH218 route compound structure diagram
    ACATRH218762240-92-6 In Stock
  4. Then
  5. ACNJVV871 route product structure diagram
    ACNJVV871-
Inquiry

Comments (0)